glp-1 ibd 🚨 RA use in is rising fast In this 14-month repeated survey of patients with IBD: 📈 GLP-1 RA use rose 5-fold ⚖️ Median BMI fell from 35.3 → 31.2 SAFETY AND CLINICAL EFFECTIVENESS OF

it's around to stay, I can tell you that

In vitro signaling studies demonstrated that tirzepatide was able to activate the GIP receptor with comparable potency to native GIP (57)

Briefly, plates were coated with collagen type 1, rat tail (Millipore, C3867), cells were plated at equal density, and cultured in IMDM (Gibco, 12440061) with 10% FBS (Gibco, 26140079) and 1% penicillin-streptomycin (Gibco, 15070063)

Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study

Clinical Risks The biggest concern here is an increased risk of bleeding